Organogenesis Holdings (ORGO) Consolidated Net Income (2016 - 2026)

Organogenesis Holdings' Consolidated Net Income history runs 11 years deep, the most recent figure standing at -$53.2 million for Q1 2026.

• In Q1 2026, Consolidated Net Income fell 182.1% year-over-year to -$53.2 million; the TTM figure through Mar 2026 stood at $12.2 million (up 176.94% YoY), while the FY2025 annual figure was $46.5 million, up 5304.41% from the prior year.
• Consolidated Net Income was -$53.2 million for Q1 2026 at Organogenesis Holdings, down from $53.2 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of $53.2 million in Q4 2025 to a low of -$53.2 million in Q1 2026.
• Historically, Consolidated Net Income has averaged $865588.2 across 5 years, with a median of $215000.0 in 2022.
• The sharpest annual moves came in 2024 and 2025: Consolidated Net Income surged 1450.88% in 2024, then plunged 797.29% in 2025.
• A 5-year view of Consolidated Net Income shows it stood at $7.5 million in 2022, then tumbled by 107.59% to -$568000.0 in 2023, then soared by 1450.88% to $7.7 million in 2024, then surged by 593.34% to $53.2 million in 2025, then plunged by 199.92% to -$53.2 million in 2026.
• The last three Consolidated Net Income figures came in at -$53.2 million (Q1 2026), $53.2 million (Q4 2025), and $21.6 million (Q3 2025), per Business Quant data.